|
1
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Torre LA, Islami F, Siegel RL, Ward EM and
Jemal A: Global cancer in women: Burden and trends. Cancer
Epidemiol Biomarkers Prev. 26:444–457. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jürgenliemk-Schulz IM, Beriwal S, de Leeuw
AAC, Lindegaard JC, Nomden CN, Pötter R, Tanderup K, Viswanathan AN
and Erickson B: Management of nodal disease in advanced cervical
cancer. Semin Radiat Oncol. 29:158–165. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mohan G and Chattopadhyay S:
Cost-effectiveness of leveraging social determinants of health to
improve breast, cervical, and colorectal cancer screening: A
systematic review. JAMA Oncol. 6:1434–1444. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bogani G, Maggiore ULR, Signorelli M,
Martinelli F, Ditto A, Sabatucci I, Mosca L, Lorusso D and
Raspagliesi F: The role of human papillomavirus vaccines in
cervical cancer: Prevention and treatment. Crit Rev Oncol Hematol.
122:92–97. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Marlow LAV, Chorley AJ, Haddrell J, Ferrer
R and Waller J: Understanding the heterogeneity of cervical cancer
screening non-participants: Data from a national sample of British
women. Eur J Cancer. 80:30–38. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Santoni G, Morelli MB, Amantini C and
Battelli N: Urinary markers in bladder cancer: An update. Front
Oncol. 8(362)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sproul D, Kitchen RR, Nestor CE, Dixon JM,
Sims AH, Harrison DJ, Ramsahoye BH and Meehan RR: Tissue of origin
determines cancer-associated CpG island promoter hypermethylation
patterns. Genome Biol. 13(R84)2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Heery R and Schaefer MH: DNA methylation
variation along the cancer epigenome and the identification of
novel epigenetic driver events. Nucleic Acids Res. 49:12692–12705.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Klutstein M, Nejman D, Greenfield R and
Cedar H: DNA methylation in cancer and aging. Cancer Res.
76:3446–3450. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Moore LD, Le T and Fan G: DNA methylation
and its basic function. Neuropsychopharmacology. 38:23–38.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Easwaran HP, Van Neste L, Cope L, Sen S,
Mohammad HP, Pageau GJ, Lawrence JB, Herman JG, Schuebel KE and
Baylin SB: Aberrant silencing of cancer-related genes by CpG
hypermethylation occurs independently of their spatial organization
in the nucleus. Cancer Res. 70:8015–8024. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bogdanović O and Lister R: DNA methylation
and the preservation of cell identity. Curr Opin Genet Dev.
46:9–14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Clarke MA, Luhn P, Gage JC, Bodelon C,
Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, et al:
Discovery and validation of candidate host DNA methylation markers
for detection of cervical precancer and cancer. Int J Cancer.
141:701–710. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yue Y, Zhou K, Li J, Jiang S, Li C and Men
H: MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch
signaling and is frequently methylated in cervical cancer. Onco
Targets Ther. 11:4769–4780. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu J, Nie S, Li S, Meng H, Sun R, Yang J
and Cheng W: Methylation-driven genes and their prognostic value in
cervical squamous cell carcinoma. Ann Transl Med.
8(868)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yu J, Xie Y, Liu Y, Wang F, Li M and Qi J:
MBD2 and EZH2 regulate the expression of SFRP1 without affecting
its methylation status in a colorectal cancer cell line. Exp Ther
Med. 20(242)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hall CL, Bafico A, Dai J, Aaronson SA and
Keller ET: Prostate cancer cells promote osteoblastic bone
metastases through Wnts. Cancer Res. 65:7554–7560. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Planutiene M, Planutis K and Holcombe RF:
Lymphoid enhancer-binding factor 1, a representative of
vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin
pathway target gene in human endothelial cells which regulates
matrix metalloproteinase-2 expression and promotes endothelial cell
invasion. Vasc Cell. 3(28)2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guo YH, Wang LQ, Li B, Xu H, Yang JH,
Zheng LS, Yu P, Zhou AD, Zhang Y, Xie SJ, et al: Wnt/β-catenin
pathway transactivates microRNA-150 that promotes EMT of colorectal
cancer cells by suppressing CREB signaling. Oncotarget.
7:42513–42526. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu Z, Wan Y, Yang M, Qi X, Dong Z, Huang
J and Xu J: Identification of methylation-driven genes related to
the prognosis of papillary renal cell carcinoma: A study based on
the cancer genome atlas. Cancer Cell Int. 20(235)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lv L, Cao L, Hu G, Shen Q and Wu J:
Methylation-driven genes identified as novel prognostic indicators
for thyroid carcinoma. Front Genet. 11(294)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Han P, Liu Q and Xiang J: Monitoring
methylation-driven genes as prognostic biomarkers in patients with
lung squamous cell cancer. Oncol Lett. 19:707–716. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lando M, Fjeldbo CS, Wilting SM, Snoek BC,
Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD and Lyng H:
Interplay between promoter methylation and chromosomal loss in gene
silencing at 3p11-p14 in cervical cancer. Epigenetics. 10:970–980.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Feinberg AP: Phenotypic plasticity and the
epigenetics of human disease. Nature. 447:433–440. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang N, Wang J, Meng X, Li T, Wang S and
Bao Y: The Pharmacological effects of spatholobi caulis tannin in
cervical cancer and its precise therapeutic effect on related
circRNA. Mol Ther Oncolytics. 14:121–129. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhong D and Cen H: Aberrant promoter
methylation profiles and association with survival in patients with
hepatocellular carcinoma. Onco Targets Ther. 10:2501–2509.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cui J, Yin Y, Ma Q, Wang G, Olman V, Zhang
Y, Chou WC, Hong CS, Zhang C, Cao S, et al: Comprehensive
characterization of the genomic alterations in human gastric
cancer. Int J Cancer. 137:86–95. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nones K, Waddell N, Song S, Patch AM,
Miller D, Johns A, Wu J, Kassahn KS, Wood D, Bailey P, et al:
Genome-wide DNA methylation patterns in pancreatic ductal
adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2
and MET signaling. Int J Cancer. 135:1110–1118. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang G, Luo X, Wang J, Wan J, Xia S, Zhu
H, Qian J and Wang Y: MeDReaders: A database for transcription
factors that bind to methylated DNA. Nucleic Acids Res.
46:D146–D151. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rasmussen KD and Helin K: Role of TET
enzymes in DNA methylation, development, and cancer. Genes Dev.
30:733–750. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jones PA and Liang G: Rethinking how DNA
methylation patterns are maintained. Nat Rev Genet. 10:805–811.
2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang X, Gao L and Zhang S: Comparative
pan-cancer DNA methylation analysis reveals cancer common and
specific patterns. Brief Bioinform. 18:761–773. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dong X, Hou Q, Chen Y and Wang X:
Diagnostic value of the methylation of multiple gene promoters in
serum in hepatitis B virus-related hepatocellular carcinoma. Dis
Markers. 2017(2929381)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Long J, Chen P, Lin J, Bai Y, Yang X, Bian
J, Lin Y, Wang D, Yang X, Zheng Y, et al: DNA methylation-driven
genes for constructing diagnostic, prognostic, and recurrence
models for hepatocellular carcinoma. Theranostics. 9:7251–7267.
2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yu J, Wu X, Huang K, Zhu M, Zhang X, Zhang
Y, Chen S, Xu X and Zhang Q: Bioinformatics identification of
lncRNA biomarkers associated with the progression of esophageal
squamous cell carcinoma. Mol Med Rep. 19:5309–5320. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chang QQ, Chen CY, Chen Z and Chang S:
LncRNA PVT1 promotes proliferation and invasion through enhancing
Smad3 expression by sponging miR-140-5p in cervical cancer. Radiol
Oncol. 53:443–452. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wang R, Li Y, Du P, Zhang X, Li X and
Cheng G: Hypomethylation of the lncRNA SOX21-AS1 has clinical
prognostic value in cervical cancer. Life Sci.
233(116708)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Xie Q, Lin S, Zheng M, Cai Q and Tu Y:
Long noncoding RNA NEAT1 promotes the growth of cervical cancer
cells via sponging miR-9-5p. Biochem Cell Biol. 97:100–108.
2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hu YC, Wang AM, Lu JK, Cen R and Liu LL:
Long noncoding RNA HOXD-AS1 regulates proliferation of cervical
cancer cells by activating Ras/ERK signaling pathway. Eur Rev Med
Pharmacol Sci. 21:5049–5055. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wei SC, Liang JT, Tsao PN, Hsieh FJ, Yu SC
and Wong JM: Preoperative serum placenta growth factor level is a
prognostic biomarker in colorectal cancer. Dis Colon Rectum.
52:1630–1636. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Han L, Husaiyin S, Ma C, Wang L and Niyazi
M: TNFAIP8L1 and FLT1 polymorphisms alter the susceptibility to
cervical cancer amongst uyghur females in China. Biosci Rep.
39(BSR20191155)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang YQ, Li YM, Li X, Liu T, Liu XK, Zhang
JQ, Guo JW, Guo LY and Qiao L: Hypermethylation of TGF-β1 gene
promoter in gastric cancer. World J Gastroenterol. 19:5557–5564.
2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Misawa Y, Misawa K, Kawasaki H, Imai A,
Mochizuki D, Ishikawa R, Endo S, Mima M, Kanazawa T, Iwashita T and
Mineta H: Evaluation of epigenetic inactivation of vascular
endothelial growth factor receptors in head and neck squamous cell
carcinoma. Tumour Biol. 39(1010428317711657)2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yamada Y, Watanabe M, Yamanaka M, Hirokawa
Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R and
Shiraishi T: Aberrant methylation of the vascular endothelial
growth factor receptor-1 gene in prostate cancer. Cancer Sci.
94:536–539. 2003.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kim JY, Hwang J, Lee SH, Lee HJ, Jelinek
J, Jeong H, Lim JS, Kim JM, Song KS, Kim BH, et al: Decreased
efficacy of drugs targeting the vascular endothelial growth factor
pathway by the epigenetic silencing of FLT1 in renal cancer cells.
Clin Epigenetics. 7(99)2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sasagawa T, Jinno-Oue A, Nagamatsu T,
Morita K, Tsuruga T, Mori-Uchino M, Fujii T and Shibuya M:
Production of an anti-angiogenic factor sFLT1 is suppressed via
promoter hypermethylation of FLT1 gene in choriocarcinoma cells.
BMC Cancer. 20(112)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Soliman NA and Yussif SM: Ki-67 as a
prognostic marker according to breast cancer molecular subtype.
Cancer Biol Med. 13:496–504. 2016.
|
|
50
|
Li R, Heydon K, Hammond ME, Grignon DJ,
Roach M III, Wolkov HB, Sandler HM, Shipley WU and Pollack A: Ki-67
staining index predicts distant metastasis and survival in locally
advanced prostate cancer treated with radiotherapy: An analysis of
patients in radiation therapy oncology group protocol 86-10. Clin
Cancer Res. 10:4118–4124. 2004.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wong E, Nahar N, Hau E, Varikatt W, Gebski
V, Ng T, Jayamohan J and Sundaresan P: Cut-point for Ki-67
proliferation index as a prognostic marker for glioblastoma. Asia
Pac J Clin Oncol. 15:5–9. 2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Song B, Wang L, Zhang Y, Li N, Dai H, Xu
H, Cai H and Yan J: Combined detection of HER2, Ki67, and GSTP1
genes on the diagnosis and prognosis of breast cancer. Cancer
Biother Radiopharm. 34:85–90. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhang SD, McCrudden CM, Meng C, Lin Y and
Kwok HF: The significance of combining VEGFA, FLT1, and KDR
expressions in colon cancer patient prognosis and predicting
response to bevacizumab. Onco Targets Ther. 8:835–843.
2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhang P, Ma Y, Wang F, Yang J, Liu Z, Peng
J and Qin H: Comprehensive gene and microRNA expression profiling
reveals the crucial role of hsa-let-7i and its target genes in
colorectal cancer metastasis. Mol Biol Rep. 39:1471–1478.
2012.PubMed/NCBI View Article : Google Scholar
|
|
55
|
O'Neill AC, Kyrousi C, Klaus J, Leventer
RJ, Kirk EP, Fry A, Pilz DT, Morgan T, Jenkins ZA, Drukker M, et
al: A primate-specific isoform of PLEKHG6 regulates neurogenesis
and neuronal migration. Cell Rep. 25:2729–2741. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
D'Angelo R, Aresta S, Blangy A, Del
Maestro L, Louvard D and Arpin M: Interaction of ezrin with the
novel guanine nucleotide exchange factor PLEKHG6 promotes
RhoG-dependent apical cytoskeleton rearrangements in epithelial
cells. Mol Biol Cell. 18:4780–4793. 2007.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Jiao M, Wu D and Wei Q: Myosin
II-interacting guanine nucleotide exchange factor promotes bleb
retraction via stimulating cortex reassembly at the bleb membrane.
Mol Biol Cell. 29:643–656. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wu Z, Wang YM, Dai Y and Chen LA: POLE2
Serves as a prognostic biomarker and is associated with immune
infiltration in squamous cell lung cancer. Med Sci Monit.
26(e921430)2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Rogers RF, Walton MI, Cherry DL, Collins
I, Clarke PA, Garrett MD and Workman P: CHK1 inhibition is
synthetically lethal with loss of B-family DNA polymerase function
in human lung and colorectal cancer cells. Cancer Res.
80:1735–1747. 2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Liu D, Zhang XX, Xi BX, Wan DY, Li L, Zhou
J, Wang W, Ma D, Wang H and Gao QL: Sine oculis homeobox homolog 1
promotes DNA replication and cell proliferation in cervical cancer.
Int J Oncol. 45:1232–1240. 2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Zekri AR, Hassan ZK, Bahnassy AA, Khaled
HM, El-Rouby MN, Haggag RM and Abu-Taleb FM: Differentially
expressed genes in metastatic advanced Egyptian bladder cancer.
Asian Pac J Cancer Prev. 16:3543–3549. 2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Li J, Wang J, Yu J, Zhao Y, Dong Y, Fan Y,
Li N, Zhang Y and Wang Y: Knockdown of POLE2 expression suppresses
lung adenocarcinoma cell malignant phenotypes in vitro.
Oncol Rep. 40:2477–2486. 2018.PubMed/NCBI View Article : Google Scholar
|
